{"id":"https://openalex.org/W2005131496","doi":"https://doi.org/10.3899/jrheum.081277","title":"Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol","display_name":"Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol","alternate_titles":[],"publication_year":2009,"publication_date":"2009-09-01","ids":{"openalex":"https://openalex.org/W2005131496","doi":"https://doi.org/10.3899/jrheum.081277","mag":"2005131496","pmid":"https://pubmed.ncbi.nlm.nih.gov/19723905"},"language":"en","primary_location":{"id":"doi:10.3899/jrheum.081277","doi":"https://doi.org/10.3899/jrheum.081277","is_oa":true,"landing_page_url":"https://doi.org/10.3899/jrheum.081277","pdf_url":"https://www.jrheum.org/content/jrheum/36/10/2244.full.pdf","source":{"id":"https://openalex.org/S50602745","display_name":"The Journal of Rheumatology","issn_l":"0315-162X","issn":["0315-162X","1499-2752"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320417","host_organization_name":"The Journal of Rheumatology Publishing Company Limited","host_organization_lineage":["https://openalex.org/P4310320417"],"host_organization_lineage_names":["The Journal of Rheumatology Publishing Company Limited"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Rheumatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005131496"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jrheum.org/content/jrheum/36/10/2244.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056518661","display_name":"David B. Badesch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"DAVID B. BADESCH","raw_affiliation_strings":["Department of Medicine, University of Colorado Denver, Denver, Colorado, USA. David.Badesch@UCHSC.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Colorado Denver, Denver, Colorado, USA. David.Badesch@UCHSC.edu","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111721656","display_name":"Michael D. McGoon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MICHAEL D. McGOON","raw_affiliation_strings":["Columbia University College of Medicine ;","Mayo Clinic College of Medicine ; R.J. Barst , MD ,","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University College of Medicine ;","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I78577930"]},{"raw_affiliation_string":"Mayo Clinic College of Medicine ; R.J. Barst , MD ,","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110145239","display_name":"Robin J. Barst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"ROBIN J. BARST","raw_affiliation_strings":["From the Department of Medicine , University of Colorado Denver , Denver , Colorado ;","Columbia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine , University of Colorado Denver , Denver , Colorado ;","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Columbia University","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025457428","display_name":"Victor F. Tapson","orcid":"https://orcid.org/0000-0001-9708-1457","observed_orcids":["https://orcid.org/0000-0001-9708-1457"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"VICTOR F. TAPSON","raw_affiliation_strings":["Department of Medicine , Division of Pulmonary Allergy and Critical Care Medicine , Duke University Medical Center ; L.J. Rubin , MD ,","Department of Medicine , Division of Pulmonary and Critical Care Medicine , University of California , San Diego ;","Duke University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine , Division of Pulmonary Allergy and Critical Care Medicine , Duke University Medical Center ; L.J. Rubin , MD ,","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Department of Medicine , Division of Pulmonary and Critical Care Medicine , University of California , San Diego ;","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Duke University","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006434846","display_name":"Lewis J. Rubin","orcid":"https://orcid.org/0000-0002-4952-5786","observed_orcids":["https://orcid.org/0000-0002-4952-5786"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"LEWIS J. RUBIN","raw_affiliation_strings":["Mayo Clinic College of Medicine , Rochester , Minnesota ;","University of California at San Diego"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic College of Medicine , Rochester , Minnesota ;","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"University of California at San Diego","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068528030","display_name":"Fredrick M. Wigley","orcid":"https://orcid.org/0000-0003-0762-6981","observed_orcids":["https://orcid.org/0000-0003-0762-6981"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"FREDRICK M. WIGLEY","raw_affiliation_strings":["Department of Medicine , Division of Rheumatology , Johns Hopkins University ; I"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine , Division of Rheumatology , Johns Hopkins University ; I","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076630877","display_name":"Kenneth M. Kral","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"KENNETH M. KRAL","raw_affiliation_strings":["From the Department of Medicine , University of Colorado Denver , Denver , Colorado ;","GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine , University of Colorado Denver , Denver , Colorado ;","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067440985","display_name":"Ibrahim Raphiou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"IBRAHIM H. RAPHIOU","raw_affiliation_strings":["From the Department of Medicine , University of Colorado Denver , Denver , Colorado ;","GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine , University of Colorado Denver , Denver , Colorado ;","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091161510","display_name":"Glenn Crater","orcid":"https://orcid.org/0000-0002-1159-1323","observed_orcids":["https://orcid.org/0000-0002-1159-1323"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"GLENN D. CRATER","raw_affiliation_strings":["Mayo Clinic College of Medicine , Rochester , Minnesota ;","GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic College of Medicine , Rochester , Minnesota ;","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5056518661"],"corresponding_institution_ids":["https://openalex.org/I921990950"],"apc_list":null,"apc_paid":null,"fwci":6.8284,"has_fulltext":true,"cited_by_count":86,"citation_normalized_percentile":{"value":0.97093408,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"36","issue":"10","first_page":"2244","last_page":"2249"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12199","display_name":"Vascular Anomalies and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/scleroderma-associated-pulmonary-arterial-hypertension","display_name":"scleroderma-associated pulmonary arterial hypertension","score":0.9259999990463257},{"id":"https://openalex.org/keywords/epoprostenol","display_name":"epoprostenol","score":0.9039999842643738},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.8009999990463257},{"id":"https://openalex.org/keywords/long-term-survival","display_name":"long-term survival","score":0.9520000219345093},{"id":"https://openalex.org/keywords/systemic-sclerosis","display_name":"systemic sclerosis","score":0.8119999766349792},{"id":"https://openalex.org/keywords/extension-study","display_name":"extension study","score":0.5630000233650208},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4959999918937683},{"id":"https://openalex.org/keywords/dosage","display_name":"dosage","score":0.675000011920929}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9692269563674927},{"id":"https://openalex.org/C2779967694","wikidata":"https://www.wikidata.org/wiki/Q1383511","display_name":"Scleroderma (fungus)","level":3,"score":0.7472023963928223},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.597282886505127},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5680320858955383},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5665345191955566},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5042859315872192},{"id":"https://openalex.org/C2780930700","wikidata":"https://www.wikidata.org/wiki/Q1128595","display_name":"Pulmonary hypertension","level":2,"score":0.47619402408599854},{"id":"https://openalex.org/C163276114","wikidata":"https://www.wikidata.org/wiki/Q484591","display_name":"Natural history","level":2,"score":0.4727880656719208},{"id":"https://openalex.org/C2779625490","wikidata":"https://www.wikidata.org/wiki/Q5340515","display_name":"Systemic scleroderma","level":3,"score":0.4483658969402313},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.425433874130249},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C2778751314","wikidata":"https://www.wikidata.org/wiki/Q681160","display_name":"Dermatomyositis","level":2,"score":0.0},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0},{"id":"https://openalex.org/C180032290","wikidata":"https://www.wikidata.org/wiki/Q1664296","display_name":"Inoculation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006976","descriptor_name":"Hypertension, Pulmonary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006976","descriptor_name":"Hypertension, Pulmonary","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006976","descriptor_name":"Hypertension, Pulmonary","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012595","descriptor_name":"Scleroderma, Systemic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.3899/jrheum.081277","doi":"https://doi.org/10.3899/jrheum.081277","is_oa":true,"landing_page_url":"https://doi.org/10.3899/jrheum.081277","pdf_url":"https://www.jrheum.org/content/jrheum/36/10/2244.full.pdf","source":{"id":"https://openalex.org/S50602745","display_name":"The Journal of Rheumatology","issn_l":"0315-162X","issn":["0315-162X","1499-2752"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320417","host_organization_name":"The Journal of Rheumatology Publishing Company Limited","host_organization_lineage":["https://openalex.org/P4310320417"],"host_organization_lineage_names":["The Journal of Rheumatology Publishing Company Limited"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Rheumatology","raw_type":"journal-article"},{"id":"pmid:19723905","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19723905","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of rheumatology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.883.6152","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.883.6152","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.jrheum.org/content/36/10/2244.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.3899/jrheum.081277","doi":"https://doi.org/10.3899/jrheum.081277","is_oa":true,"landing_page_url":"https://doi.org/10.3899/jrheum.081277","pdf_url":"https://www.jrheum.org/content/jrheum/36/10/2244.full.pdf","source":{"id":"https://openalex.org/S50602745","display_name":"The Journal of Rheumatology","issn_l":"0315-162X","issn":["0315-162X","1499-2752"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320417","host_organization_name":"The Journal of Rheumatology Publishing Company Limited","host_organization_lineage":["https://openalex.org/P4310320417"],"host_organization_lineage_names":["The Journal of Rheumatology Publishing Company Limited"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Rheumatology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005131496.pdf","grobid_xml":"https://content.openalex.org/works/W2005131496.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1972469636","https://openalex.org/W1979493555","https://openalex.org/W1988773573","https://openalex.org/W2018426574","https://openalex.org/W2039685181","https://openalex.org/W2054202576","https://openalex.org/W2055147321","https://openalex.org/W2066664983","https://openalex.org/W2069038734","https://openalex.org/W2070022895","https://openalex.org/W2085375516","https://openalex.org/W2087684678","https://openalex.org/W2097973238","https://openalex.org/W2101469388","https://openalex.org/W2112872457","https://openalex.org/W2118466998","https://openalex.org/W2135510321","https://openalex.org/W2137071299","https://openalex.org/W2148965526","https://openalex.org/W2149839143","https://openalex.org/W2161347639","https://openalex.org/W2321522617","https://openalex.org/W2341035105","https://openalex.org/W2411333845","https://openalex.org/W2614800967","https://openalex.org/W2988610037"],"related_works":["https://openalex.org/W2028741241","https://openalex.org/W2135510321","https://openalex.org/W2054202576","https://openalex.org/W2009495883","https://openalex.org/W7213441789","https://openalex.org/W2279961791","https://openalex.org/W2073305297","https://openalex.org/W4246492178","https://openalex.org/W2018621622","https://openalex.org/W2982345709"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Pulmonary":[1],"arterial":[2],"hypertension":[3],"(PAH)":[4],"remains":[5],"challenging":[6],"to":[7,196],"treat,":[8],"especially":[9],"in":[10,22,35,57,66,83,101,109,115],"association":[11,23,58],"with":[12,20,24,55,59,187,191,202,217],"scleroderma.":[13],"We":[14],"examined":[15],"survival":[16,137,183,209],"rates":[17,184],"among":[18],"patients":[19,53,73,90,114,186,216],"PAH":[21,56,72,189],"scleroderma":[25,60],"who":[26,61,80,106,147],"received":[27,62,81,107,119,148],"epoprostenol":[28,63,82,108,149],"(Flolan)":[29],"through":[30],"continuous":[31],"intravenous":[32],"(i.v.)":[33],"infusion":[34],"an":[36,43,92],"uncontrolled":[37],"open-label":[38,120],"3-year":[39],"extension":[40,111,117,159],"study":[41,118,155,160,180,205],"following":[42],"initial":[44,93,152],"randomized,":[45],"controlled":[46,86,104,154],"12-week":[47],"study.":[48,112,132],"METHODS:":[49],"One":[50],"hundred":[51],"two":[52],"diagnosed":[54],"were":[64,128,161],"included":[65,70],"the":[67,84,102,110,131,139,151,158,173],"analyses.":[68],"This":[69,166,179],"51":[71],"from":[74,91],"a":[75,207],"subject":[76],"population":[77,94],"of":[78,95,136],"56":[79],"randomized":[85,103,153],"study,":[87,105],"and":[88,125,141,163,175],"46":[89],"55":[96],"subjects":[97,146],"on":[98,215],"conventional":[99],"therapy":[100],"All":[113],"this":[116,204],"epoprostenol.":[121,193],"Adverse":[122],"events,":[123],"survival,":[124],"dosing":[126],"information":[127],"collected":[129],"throughout":[130],"RESULTS:":[133],"The":[134],"probabilities":[135],"during":[138,150,157,172],"first":[140],"second":[142],"years":[143],"for":[144,185],"all":[145],"or":[156],"0.71":[162],"0.52,":[164],"respectively.":[165],"measure":[167],"remained":[168],"constant":[169],"at":[170],"0.48":[171],"third":[174],"fourth":[176],"years.":[177],"CONCLUSION:":[178],"reports":[181,206],"longterm":[182],"scleroderma-associated":[188,218],"treated":[190],"i.v.":[192],"Although":[194],"comparisons":[195],"historical":[197],"data":[198,214],"should":[199],"be":[200],"made":[201],"caution,":[203],"better":[208],"outcome":[210],"than":[211],"natural":[212],"history":[213],"PAH.":[219]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005131496","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
